| +0.14 / +0.17%|
The 24 analysts offering 12-month price forecasts for Novartis AG have a median target of 86.32, with a high estimate of 97.11 and a low estimate of 68.42. The median estimate represents a +3.96% increase from the last price of 83.04.
The current consensus among 31 polled investment analysts is to Hold stock in Novartis AG. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.